SoftBank Group (9984) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
3 Feb, 2026Executive summary
Achieved first net profit in four years, with net income of ¥1,153.3 billion, up ¥1,380.9 billion year-over-year, driven by investment gains and improved performance in key holdings.
Net asset value at March-end: ¥25.7 trillion, down ¥2.1 trillion year-over-year, mainly due to weaker tech stock performance, but recovered to ¥27.4 trillion pro forma.
Major strategic actions included the Stargate Project with OpenAI and Oracle, up to $40 billion investment commitment in OpenAI, and the planned $6.5 billion acquisition of Ampere.
Shareholder returns included up to ¥500 billion authorized for share repurchases, with ¥286.2 billion completed, and a proposed annual dividend of ¥44 per share.
Financial highlights
Net sales: ¥7,243.8 billion, up ¥487.3 billion or 7.2% year-over-year.
Net income attributable to owners: ¥1,153.3 billion (vs. ¥227.6 billion loss prior year); basic EPS: ¥780.82.
Investment gains: ¥3,701.1 billion, up from a ¥559.4 billion loss prior year.
Cash and cash equivalents at year-end: ¥3.4 trillion, down from ¥4.7 trillion year-over-year.
Loan to value: 18% at March-end, up from 8.4% year-over-year, with a policy to keep below 25%.
Outlook and guidance
Continued focus on AI, data centers, and energy as strategic pillars.
Arm's Q1 FY2025 revenue guidance: $1.0–$1.1 billion, up 6.5%–17.1% year-over-year; non-GAAP EPS: $0.30–$0.38.
Dividend per share maintained at ¥44 for FY2025.
Ongoing commitment to maintain financial discipline and readiness to shift to defensive operations if needed.
Latest events from SoftBank Group
- Net income soared 398.7% on investment gains and strategic AI expansion, led by OpenAI.9984
Q3 202612 Feb 2026 - A $3B joint venture launches to deploy advanced enterprise AI agents in Japan and beyond.9984
Partnership3 Feb 2026 - Net income surged to ¥636.2B on investment gains, Arm growth, and strong financial discipline.9984
Q3 20253 Feb 2026 - AI-powered precision medicine launches in Japan, targeting 1M annual genomic tests and data-driven care.9984
Status Update3 Feb 2026 - Shareholder value hit JPY 34T, Arm led growth, and all proposals passed amid an ASI vision.9984
AGM 20243 Feb 2026 - Record NAV, Arm's record revenue, and Vision Fund 1 gains highlight robust AI-driven results.9984
Q1 20252 Feb 2026 - Net income surged to ¥1,005.3B, led by Vision Fund, T-Mobile, and Arm's record sales.9984
Q2 202515 Jan 2026 - AI-driven demand, advanced chip designs, and ecosystem partnerships fuel strong growth.9984
Investor Update1 Dec 2025 - Net income hit ¥421.8B, with record NAV and share price, led by Arm, Vision Fund, and OpenAI.9984
Q1 202623 Nov 2025